Page 3 - ஜெமிநை சிகிச்சை இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஜெமிநை சிகிச்சை இன்க். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஜெமிநை சிகிச்சை இன்க் Today - Breaking & Trending Today

Gemini Therapeutics Appoints Samuel Barone, M.D., as Chief Medical Officer


Press release content from Business Wire. The AP news staff was not involved in its creation.
Gemini Therapeutics Appoints Samuel Barone, M.D., as Chief Medical Officer
April 12, 2021 GMT
CAMBRIDGE, Mass. (BUSINESS WIRE) Apr 12, 2021
Gemini Therapeutics, Inc. (Nasdaq: GMTX), a clinical stage precision medicine company developing innovative treatments for genetically defined age-related macular degeneration (AMD) and linked ocular disorders, today announced the appointment of Samuel Barone, M.D., as Gemini’s Chief Medical Officer, effective immediately.
“We are thrilled to welcome Sam to Gemini as Chief Medical Officer, where he will bring his expertise as a board-certified ophthalmologist specializing in the treatment of retinal and macular diseases,” said Jason Meyenburg, Chief Executive Officer of Gemini Therapeutics. “As we continue to advance our clinical pipeline, we will benefit tremendously from his two-plus decades of clinical and development e ....

New York , United States , Boston College , San Diego , United Kingdom , Sherri Spear , Joshua Mansbach , Jason Meyenburg , Marce Uknis , Samuel Barone , University Of California , United States Air , Office Of Cellular , Drug Administration , Pennsylvania State University College Of Medicine , Andrews Air Force , Gemini Therapeutics Inc , Chief Medical Officer , Chief Executive Officer , Gemini Therapeutics , Senior Vice President , Adverum Biotechnologies , Avalanche Biotechnologies , Chief Medical , Medical Officer , Gene Therapies ,

Gemini Therapeutics Appoints Brian Piekos as Chief Financial Officer


Posted on
256
Gemini Therapeutics, Inc., (Nasdaq: GMTX) a clinical stage precision medicine company developing innovative treatments for genetically defined age-related macular degeneration (AMD), today announced that Brian Piekos has been appointed to serve as Chief Financial Officer. Mr. Piekos brings more than 20 years of experience in industry and finance to Gemini.
“It is my pleasure to welcome Brian to the team at this exciting time in Gemini’s history right on the heels of our debut as a public company,” said Jason Meyenburg, Chief Executive Officer of Gemini. “Brian’s deep financial experience and results-driven attitude will be invaluable to us as we continue to develop first-in-class medicines, using insights in genetics and biology, to restore regulation of the complement system in the eye and throughout the body.” ....

United States , Sherri Spear , Joshuar Mansbach , Brian Piekos , Jason Meyenburg , University Of Massachusetts Medical School , Ithaca College , Needham Company , Cubist Pharmaceuticals , Gemini Therapeutics Inc , Simon Business School , University Of Rochester , Gemini Therapeutics , Chief Financial , Chief Executive Officer , Executive Vice President , Chief Financial Officer , Corporate Finance , Leerink Partners , Massachusetts Medical School , Dry Age Related Macular Degeneration , ஒன்றுபட்டது மாநிலங்களில் , ஷெர்ரி ஈட்டி , பல்கலைக்கழகம் ஆஃப் மாசசூசெட்ஸ் மருத்துவ பள்ளி , இத்தாக்கா கல்லூரி , நீட்ஹாம் நிறுவனம் ,

(GMTX) - Gemini Therapeutics Completes 60 Patients Enrollment In Lead Candidate Mid-Stage Study In Dry AMD

(GMTX) - Gemini Therapeutics Completes 60 Patients Enrollment In Lead Candidate Mid-Stage Study In Dry AMD
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Gemini Therapeutics Inc , Fast Track Designation , ஜெமிநை சிகிச்சை இன்க் , வேகமாக டிராக் பதவி ,